Embodiments of the present disclose provide a method of sorbing one or more compounds from a fluid, wherein the method may include contacting a M-soc-MOF composition with a fluid containing at least H.sub.2S and one or more of CO.sub.2 and CH.sub.4; and sorbing at least H.sub.2S from the fluid. Embodiments of the present disclosure provide a membrane that may include a metal-organic framework (MOF) composition, wherein the MOF composition includes a M-soc-MOF composition, where M is a metal and soc is a square-octahedral topology, and wherein the M-soc-MOF composition is a continuous thin film on a support.

A light-emitting device includes: a first electrode; a second electrode facing the first electrode; and an interlayer between the first electrode and the second electrode and including an emission layer, wherein the interlayer includes a heterocyclic compound of Formula 1:

A.sub.1B.sub.1].sub.n1  Formula 1

wherein, in Formula 1, the variables are defined herein.

Metal Organic Framework (MOF) materials and methods of making MOF materials. The methods include grinding of mixtures of metal hydroxide(s) and ligand(s). The MOF materials may have at least two different ligands. The MOF materials may have open metal sites. The MOF materials can be used in gas storage applications.

The present invention relates to a process for preparing a metal-chelate retarder by a sol-gel method. The method comprises the following steps: weighing calcium nitrate tetrahydrate, aluminum nitrate nonahydrate and ferric nitrate nonahydrate according to a certain mass ratio and adding them into deionized water; placing the mixed solution on a magnetic stirrer and stirring the mixed solution evenly; adding citric acid monohydrate or gluconic acid, ethylene glycol or glycerol, and placing the mixed solution into a water bath to react to obtain the metal-chelate retarder. The process of the present invention has a reliable principle, overcomes the defects of long production period, complex preparation and the like of the existing retarders, has the advantages of simple process operation, cheap and easily available raw materials, and short production period. The prepared retarder has wide temperature adaptation range and adjustable thickening time, is suitable for large-scale industrial production, and has a wide market application prospect.

The present invention relates to precursor compounds, and more particularly to nonpyrophoric precursor compounds suitable for use in thin film deposition through atomic layer deposition (ALD) or chemical vapor deposition (CVD), and to an ALD/CVD process using the same.

The present invention relates to precursor compounds, and more particularly to nonpyrophoric precursor compounds suitable for use in thin film deposition through atomic layer deposition (ALD) or chemical vapor deposition (CVD), and to an ALD/CVD process using the same.

The present invention relates to a metal-organic framework (MOF) having a three-dimensional porous structure and being represented by the chemical formula of [Al.sub.8(OH).sub.a(BTC).sub.b(IPA).sub.c(L).sub.d], a preparation method therefor, and a use thereof as an adsorbent and a catalyst.

The present invention relates to a polycyclic aromatic derivative compound that can be employed in an organic layer in a device, and an organoelectroluminescent device with high-efficiency and a long-life, including same and having remarkably improved luminous efficiency, and the device employing same can be efficiently utilized in a variety of displays and lighting devices, such as a flat panel display device, a flexible display device, a single color or white flat lighting device, and a single color or white flexible lighting device.

The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FAP ligands for targeting applications, in particular diagnostic methods and/or methods for therapy or surgery in relation to a disease or disorder, such as cancer, inflammation or another disease characterized by overexpression of FAP.

An apparatus for purifying an organic compound and a method of purifying an organic compound, the apparatus including an inner tube that receives a purification target material therein; a heater that heats the purification target material received in the inner tube; an evacuator that evacuates the inner tube into a vacuum; and a driving device that drives the inner tube.